The University of Iowa Institute for Clinical and Translational Science (ICTS) opened its Clinical Research Unit (CRU) November 18. The new 20,000 square-foot, state-of-the-art facility represents a major milestone for ICTS because it provides the necessary infrastructure to conduct quality clinical and translational research.
The CRU is open to all University of Iowa investigators and includes a number of specialized laboratories such as the pulmonary physiology, bionutrition and cardiovascular physiology labs. These core laboratories are equipped with advanced technologies, including the BodPod™, which provides highly sensitive and reliable measures of body composition, and Dual Energy X-ray Absorptiometry that assesses bone density in adults, infants, and children.
The CRU’s Cardiovascular Physiology Lab is among only a handful of institutions in the world (and the only one in the USA) with expertise in performing procedures including intra-arterial administration of drugs, central venous pressure monitoring, and recording of sympathetic nerve activity.
The Pulmonary Physiology Core supports airway sample collections using bronchoscopy and sputum induction, as well as pulmonary function and cardiopulmonary exercise testing.
The ICTS is one of 55 participating medical research institutions working together as a national consortium to improve biomedical research. The consortium, funded through Clinical and Translational Science Awards (CTSA), shares a common vision to reduce the time it takes for laboratory discoveries to become treatments for patients. It also fulfills the critical need to train a new generation of clinical researchers and serves to engage communities in clinical research efforts. The CTSA program is led by the National Center for Research Resources, part of National Institutes of Health.